269 related articles for article (PubMed ID: 34244072)
21. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
[TBL] [Abstract][Full Text] [Related]
22. Bone health and body composition in transgender adults before gender-affirming hormonal therapy: data from the COMET study.
Ceolin C; Scala A; Dall'Agnol M; Ziliotto C; Delbarba A; Facondo P; Citron A; Vescovi B; Pasqualini S; Giannini S; Camozzi V; Cappelli C; Bertocco A; De Rui M; Coin A; Sergi G; Ferlin A; Garolla A;
J Endocrinol Invest; 2024 Feb; 47(2):401-410. PubMed ID: 37450195
[TBL] [Abstract][Full Text] [Related]
23. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
24. Early postnatal methoxychlor exposure inhibits folliculogenesis and stimulates anti-Mullerian hormone production in the rat ovary.
Uzumcu M; Kuhn PE; Marano JE; Armenti AE; Passantino L
J Endocrinol; 2006 Dec; 191(3):549-58. PubMed ID: 17170213
[TBL] [Abstract][Full Text] [Related]
25. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
26. Reproductive functions and fertility preservation in transgender women: a French case series.
Sermondade N; Benaloun E; Berthaut I; Moreau E; Prades M; Béranger A; Chabbert-Buffet N; Johnson N; Lévy R; Dupont C
Reprod Biomed Online; 2021 Aug; 43(2):339-345. PubMed ID: 34144898
[TBL] [Abstract][Full Text] [Related]
27. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
28. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
[TBL] [Abstract][Full Text] [Related]
29. Oocyte matched follicular fluid anti-Müllerian hormone is an excellent predictor of live birth after fresh single embryo transfer.
Ciepiela P; Dulęba AJ; Kario A; Chełstowski K; Branecka-Woźniak D; Kurzawa R
Hum Reprod; 2019 Nov; 34(11):2244-2253. PubMed ID: 31725884
[TBL] [Abstract][Full Text] [Related]
30. Ovarian Histopathology in Transmasculine Persons on Testosterone: A Multicenter Case Series.
Grimstad FW; Fowler KG; New EP; Ferrando CA; Pollard RR; Chapman G; Gray M; Gomez Lobo V
J Sex Med; 2020 Sep; 17(9):1807-1818. PubMed ID: 32703706
[TBL] [Abstract][Full Text] [Related]
31. Reproductive Endocrinology Reference Intervals for Transgender Women on Stable Hormone Therapy.
Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Dickerson JA; Drees JC; Humble RM; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2021 Jan; 6(1):15-26. PubMed ID: 32674116
[TBL] [Abstract][Full Text] [Related]
32. Family Building Perspectives of Assigned Female at Birth Transgender and Gender Diverse Adolescents Seeking Testosterone Gender-Affirming Hormone Therapy.
Garborcauskas G; McCabe E; Boskey ER; Grimstad FW
LGBT Health; 2022 Oct; 9(7):463-470. PubMed ID: 35802494
[No Abstract] [Full Text] [Related]
33. TESTOSTERONE LEVELS ACHIEVED BY MEDICALLY TREATED TRANSGENDER WOMEN IN A UNITED STATES ENDOCRINOLOGY CLINIC COHORT.
Liang JJ; Jolly D; Chan KJ; Safer JD
Endocr Pract; 2018 Feb; 24(2):135-142. PubMed ID: 29144822
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular implications of gender-affirming hormone treatment in the transgender population.
Dutra E; Lee J; Torbati T; Garcia M; Merz CNB; Shufelt C
Maturitas; 2019 Nov; 129():45-49. PubMed ID: 31547912
[TBL] [Abstract][Full Text] [Related]
35. Anti-Müllerian hormone promotes pre-antral follicle growth, but inhibits antral follicle maturation and dominant follicle selection in primates.
Xu J; Bishop CV; Lawson MS; Park BS; Xu F
Hum Reprod; 2016 Jul; 31(7):1522-30. PubMed ID: 27165618
[TBL] [Abstract][Full Text] [Related]
36. The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.
Li J; Li R; Yu H; Zhao S; Yu Y; Qiao J
Syst Biol Reprod Med; 2015 Apr; 61(2):103-9. PubMed ID: 25329139
[TBL] [Abstract][Full Text] [Related]
37. [Hormone treatment of transgender people: Long-term health effects and safety].
de Blok CJM; Wiepjes CM; Nota NM; den Heijer M
Ned Tijdschr Geneeskd; 2020 Jul; 164():. PubMed ID: 32757514
[TBL] [Abstract][Full Text] [Related]
38. Risk for Venous Thromboembolism in Transgender Patients Undergoing Cross-Sex Hormone Treatment: A Systematic Review.
Kotamarti VS; Greige N; Heiman AJ; Patel A; Ricci JA
J Sex Med; 2021 Jul; 18(7):1280-1291. PubMed ID: 34140253
[TBL] [Abstract][Full Text] [Related]
39. Anti-Müllerian hormone inhibits activation and growth of bovine ovarian follicles in vitro and is localized to growing follicles.
Yang MY; Cushman RA; Fortune JE
Mol Hum Reprod; 2017 May; 23(5):282-291. PubMed ID: 28333275
[TBL] [Abstract][Full Text] [Related]
40. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.
Kedem-Dickman A; Maman E; Yung Y; Yerushalmi GM; Hemi R; Hanochi M; Dor J; Hourvitz A
Reprod Biomed Online; 2012 May; 24(5):540-6. PubMed ID: 22421733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
